Kyungsun Kyle Choi is a foreign attorney in the firm's Health and Digital Healthcare Practice and is a member of the Mergers & Acquisitions and Corporate Investigations & White Collar Defense Practice. She also advises chemical and related industry clients including consumer goods on EH&S regulations that have been undergoing rapid changes with focused enforcement activities.
Ms. Choi works with a broad range of companies in the pharmaceutical/medical device/food/cosmetic sectors, specializing in pharmaceutical regulation, pricing and reimbursement, compliance, bribery and competition law issues relating to promotional and marketing practices in the industry, anti-counterfeiting strategies, M&A, and restructuring of business operations.
Ms. Choi’s representative work in recent years includes advising pharmaceutical clients in negotiating price and reimbursement scope of innovative drugs as well as in renewal of contract under a Risk Sharing Program. She also advised on a major multinational pharmaceutical company in a drug price reduction and reimbursement suspension case due to alleged illegal marketing activities. Ms. Choi also regularly advises clients in negotiating settlement discussions on alleged adverse effect cases in clinical studies and product liabilities litigations.
Ms. Choi has vast experience advising multiple clients in the pharmaceutical industry in a wide range of internal and government investigations for corporate fraud, corruption, fair trade law, and anti-bribery offenses.
